SG&A Efficiency Analysis: Comparing Perrigo Company plc and Vericel Corporation

SG&A Efficiency: A Tale of Two Companies

In the ever-evolving landscape of corporate finance, understanding a company's efficiency in managing its Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Perrigo Company plc and Vericel Corporation have showcased contrasting trajectories in their SG&A expenditures.

Perrigo, a global leader in consumer self-care products, has seen its SG&A expenses grow by approximately 89% from 2014 to 2023. This increase reflects strategic investments in marketing and administration to bolster its market position. In contrast, Vericel, a pioneer in advanced cell therapies, has experienced a staggering 779% rise in SG&A expenses over the same period. This surge underscores Vericel's aggressive expansion and scaling efforts in the biopharmaceutical sector.

As we delve into these figures, it becomes evident that while both companies are expanding, their strategies and market dynamics differ significantly, offering valuable insights into their operational priorities.